<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="IE=edge" http-equiv="X-UA-Compatible"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../img/favicon.ico" rel="shortcut icon"/>
<title>Heart failure - MediWiki</title>
<link href="../../css/bootstrap.min.css" rel="stylesheet"/>
<link href="../../css/font-awesome.min.css" rel="stylesheet"/>
<link href="../../css/base.css" rel="stylesheet"/>
<link href="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/10.5.0/styles/color-brewer.min.css" rel="stylesheet"/>
<script defer="" src="../../js/jquery-1.10.2.min.js"></script>
<script defer="" src="../../js/bootstrap.min.js"></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/10.5.0/highlight.min.js"></script>
<script>hljs.initHighlightingOnLoad();</script>
</head>
<body>
<div class="navbar fixed-top navbar-expand-lg navbar-dark bg-primary">
<div class="container">
<a class="navbar-brand" href="../..">MediWiki</a>
<!-- Expander button -->
<button class="navbar-toggler" data-target="#navbar-collapse" data-toggle="collapse" type="button">
<span class="navbar-toggler-icon"></span>
</button>
<!-- Expanded navigation -->
<div class="navbar-collapse collapse" id="navbar-collapse">
<!-- Main navigation -->
<ul class="nav navbar-nav">
<li class="navitem">
<a class="nav-link" href="../../Basic%20Clinical%20Sciences.html">Basic Clinical Sciences</a>
</li>
<li class="navitem">
<a class="nav-link" href="../../Internal%20Medicine.html">Internal Medicine</a>
</li>
<li class="navitem">
<a class="nav-link" href="../../Surgery.html">Surgery</a>
</li>
<li class="navitem">
<a class="nav-link" href="../../Psychiatry.html">Psychiatry</a>
</li>
<li class="navitem">
<a class="nav-link" href="../../Critical%20Care.html">Critical Care</a>
</li>
</ul>
<ul class="nav navbar-nav ml-auto">
<li class="nav-item">
<a class="nav-link" data-target="#mkdocs_search_modal" data-toggle="modal" href="#">
<i class="fa fa-search"></i> Search
                            </a>
</li>
<li class="nav-item">
<a class="nav-link" href="First%20degree%20AV%20block.html" rel="prev">
<i class="fa fa-arrow-left"></i> Previous
                                </a>
</li>
<li class="nav-item">
<a class="nav-link" href="Hypertension%20in%20children.html" rel="next">
                                    Next <i class="fa fa-arrow-right"></i>
</a>
</li>
</ul>
</div>
</div>
</div>
<div class="container">
<div class="row">
<div class="col-md-3"><div class="navbar-light navbar-expand-md bs-sidebar hidden-print affix" role="complementary">
<div class="navbar-header">
<button class="navbar-toggler collapsed" data-target="#toc-collapse" data-toggle="collapse" title="Table of Contents" type="button">
<span class="fa fa-angle-down"></span>
</button>
</div>
<div class="navbar-collapse collapse card bg-secondary" id="toc-collapse">
<ul class="nav flex-column">
<li class="nav-item" data-level="1"><a class="nav-link" href="#heart-failure">Heart failure</a>
<ul class="nav flex-column">
<li class="nav-item" data-level="2"><a class="nav-link" href="#background">Background</a>
<ul class="nav flex-column">
</ul>
</li>
<li class="nav-item" data-level="2"><a class="nav-link" href="#pathology">Pathology</a>
<ul class="nav flex-column">
</ul>
</li>
<li class="nav-item" data-level="2"><a class="nav-link" href="#classification">Classification</a>
<ul class="nav flex-column">
</ul>
</li>
<li class="nav-item" data-level="2"><a class="nav-link" href="#clinical-features">Clinical features</a>
<ul class="nav flex-column">
</ul>
</li>
<li class="nav-item" data-level="2"><a class="nav-link" href="#diagnosis">Diagnosis</a>
<ul class="nav flex-column">
</ul>
</li>
</ul>
</li>
<li class="nav-item" data-level="1"><a class="nav-link" href="#heart-failure-with-reduced-ejection-fraction-hfref">Heart failure with reduced ejection fraction (HFrEF)</a>
<ul class="nav flex-column">
<li class="nav-item" data-level="2"><a class="nav-link" href="#management">Management</a>
<ul class="nav flex-column">
</ul>
</li>
</ul>
</li>
<li class="nav-item" data-level="1"><a class="nav-link" href="#heart-failure-with-preserved-ejection-fraction-hfpef">Heart failure with preserved ejection fraction (HFpEF)</a>
<ul class="nav flex-column">
<li class="nav-item" data-level="2"><a class="nav-link" href="#management_1">Management</a>
<ul class="nav flex-column">
</ul>
</li>
</ul>
</li>
</ul>
</div>
</div></div>
<div class="col-md-9" role="main">
<h1 id="heart-failure">Heart failure</h1>
<h2 id="background">Background</h2>
<ul>
<li>CHF is a clinical syndrome resulting from the heart’s inability to meet the body’s circulatory demands under normal physiologic conditions. It is the final common pathway for a wide variety of cardiac diseases (see also Clinical Pearl 1-7).</li>
<li>Causes<ul>
<li>Most commonly caused by ischemia (IHD) → typically causes systolic dysfunction (low EF)<ul>
<li>myocardium CANNOT CONTRACT, but can relax → this is a systolic dysfunction (HFrEF picture)</li>
</ul>
</li>
<li>Hypertension → typically causes diastolic CHF (high EF)<ul>
<li>myocardium can contract heart, but CANNOT RELAX because the muscles are too hypertrophied (HFpEF picture)</li>
</ul>
</li>
<li>Valvular disorder</li>
</ul>
</li>
</ul>
<h2 id="pathology">Pathology</h2>
<ul>
<li>Frank–Starling relationship<ul>
<li>In a normal heart, increasing preload results in greater contractility. When preload is low (at rest), there is little difference in performance between a normal and a failing heart.</li>
<li>However, with exertion a failing heart produces relatively less contractility and symptoms occur</li>
</ul>
</li>
<li>Left heart failure: Alveolar oedema presents with pink transulate<ul>
<li>alveolar macrophages present, filled with haemosiderin, called heart failure cells (HF cells):  rupture of pulmonary capillaries → RBCs enter alveoli and phagocytosed by alveolar MPs → excess iron in macrophages →  iron binds to ferritin → degrades into haemosiderin → produces a rust-coloured sputum</li>
</ul>
</li>
<li>Right heart failure: hepatomegaly due to hepatic congestion<ul>
<li>centrilobular haemorrhagic necrosis - due to reduced oxygen tension and a lack of blood flow to the centrilobular region</li>
</ul>
</li>
</ul>
<h2 id="classification">Classification</h2>
<ul>
<li>HFrEF (systolic) vs HFpEF (diastolic) determines prognosis and pathology<ul>
<li>Heart Failure with reduced Ejection Fraction (HFrEF) or systolic dysfunction<ul>
<li>Owing to impaired contractility (reduced EF &lt;40%) or increased afterload<ul>
<li>reduced EF → increased preload → F-S law → increased myocardial contractility → myocardial hypertrophy and ventricular dilation</li>
<li>Myocardial infarct → cellular death → reduced contractile cells in the heart → eccentric hypertrophy of the heart → HFrEF</li>
</ul>
</li>
<li>Causes include:<ul>
<li>Ischemic heart disease or after a recent MI—infarcted cardiac muscle does not pump blood (decreased EF)</li>
<li>Myocarditis (postviral, giant cell, autoimmune)</li>
<li>Valvular heart disease (usually MR, aortic regurgitation)</li>
<li>Dilated cardiomyopathy:<ul>
<li>Drugs: Alcohol, cocaine, methamphetamines, chemotherapy (anthracyclines and trastuzumab)</li>
<li>Infiltrative disease (amyloidosis, sarcoidosis, hemochromatosis, Wilson disease)</li>
<li>Radiation therapy</li>
<li>Thyroid disease</li>
<li>Peripartum cardiomyopathy</li>
<li>Infectious disease (Chagas disease, HIV, endocarditis causing valvular disease)</li>
<li>Congenital/hereditary</li>
</ul>
</li>
<li>High-output heart failure (severe anemia, due to AV fistulas, pregnancy, severe thiamine deficiency)</li>
</ul>
</li>
</ul>
</li>
<li>Heart Failure with preserved Ejection Fraction (HFpEF) or diastolic dysfunction<ul>
<li>Owing to impaired ventricular filling during diastole (either impaired relaxation or increased stiffness of ventricle or both).</li>
<li>Echocardiogram shows impaired relaxation of left ventricle.</li>
<li>Causes include:<ul>
<li>HTN leading to myocardial hypertrophy—most common cause of diastolic dysfunction</li>
<li>Valvular diseases such as aortic stenosis (AS), mitral stenosis, and aortic regurgitation</li>
<li>Restrictive cardiomyopathy<ul>
<li>(e.g., amyloidosis, sarcoidosis, hemochromatosis in their early phases)</li>
</ul>
</li>
<li>Obstructive cardiomyopathy<ul>
<li>HOCM</li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
<li>Left-sided vs. Right-sided heart failure determines symptoms</li>
</ul>
<h2 id="clinical-features">Clinical features</h2>
<ul>
<li>Symptoms of left-sided heart failure<ul>
<li>Forward failure:<ul>
<li>Confusion and memory impairment occur in advanced CHF as a result of inadequate brain perfusion</li>
<li>Diaphoresis and cool extremities at rest—occur in desperately ill patients (NYHA class IV)</li>
</ul>
</li>
<li>Backwards failure<ul>
<li>Dyspnea—difficulty breathing secondary to pulmonary congestion/edema</li>
<li>Orthopnea—difficulty breathing in the recumbent position; relieved by elevation of the head with pillows</li>
<li>Paroxysmal nocturnal dyspnea (PND)—awakening after 1 to 2 hours of sleep due to acute shortness of breath (SOB)</li>
<li>Nocturnal cough (nonproductive)—worse in recumbent position (same pathophysiology as orthopnea)</li>
</ul>
</li>
</ul>
</li>
<li>Signs of left-sided heart failure<ul>
<li>Displaced PMI (usually to the left) due to cardiomegaly</li>
<li>Pathologic S3 (ventricular gallop) - indicative of a systolic heart failure (splashing into leftover blood)<ul>
<li>Rapid filling phase “into” a noncompliant left ventricular chamber</li>
<li>May be normal finding in children; in adults, usually associated with CHF</li>
<li>May be difficult to hear, but is among the most specific signs of CHF</li>
<li>Heard best at apex with bell of stethoscope<ul>
<li>The sequence in the cardiac cycle for S3: S3 follows S2 (ken-tuck-Y)</li>
</ul>
</li>
</ul>
</li>
<li>S4 gallop - indicative of a diastolic heart failure (pushing blood into a stiff ventricle)<ul>
<li>Sound of atrial systole as blood is ejected into a noncompliant, or stiff, left ventricular chamber</li>
<li>Heard best at left sternal border with bell of stethoscope</li>
<li>The sequence in the cardiac cycle for S4: S4 precedes S1 (TEN-nes-see)</li>
</ul>
</li>
<li><strong>Crackles/rales at lung bases</strong><ul>
<li>Caused by fluid spilling into alveoli; indicates pulmonary edema</li>
<li>Rales heard over lung bases suggest at least moderate severity of left ventricular heart failure</li>
</ul>
</li>
<li>Dullness to percussion and decreased tactile fremitus of lower lung fields caused by pleural effusion → fluid in the pleural space will absorb all the sound</li>
<li>Increased intensity of pulmonic component of second heart sound suggests pulmonary HTN (heard over left upper sternal border)</li>
</ul>
</li>
<li>Symptoms/signs of right-sided heart failure<ul>
<li>Backwards failure:<ul>
<li>Peripheral pitting edema—pedal edema lacks specificity as an isolated finding.<ul>
<li>In the elderly, it is more likely to be secondary to venous insufficiency</li>
</ul>
</li>
<li>Nocturia—due to increased venous return with elevation of legs</li>
<li>Jugular venous distention (JVD)</li>
<li>Hepatomegaly/hepatojugular reflux</li>
<li>Ascites</li>
<li>Right ventricular heave (found with pulmonary HTN)</li>
</ul>
</li>
</ul>
</li>
<li>Given enough time, left-sided heart failure can lead to right-sided heart failure (most common cause right-sided heart failure)<ul>
<li>Patients may present with sign/symptoms of both right- and left-sided HF</li>
</ul>
</li>
</ul>
<h2 id="diagnosis">Diagnosis</h2>
<ul>
<li>Chest x-ray (CXR) (ABCDE)<ul>
<li>Alveolar oedema</li>
<li>Kerley B lines are short horizontal lines near periphery of the lung near the costophrenic angles, and indicate pulmonary congestion secondary to dilation of pulmonary lymphatic vessels</li>
<li>Cardiomegaly</li>
<li>Dilated Prominent interstitial markings</li>
<li>Pleural effusion</li>
</ul>
</li>
<li><strong>Echocardiogram (transthoracic)</strong><ul>
<li>Initial test of choice—should be performed whenever CHF is suspected based on history, examination, or CXR.</li>
<li>Useful in determining whether systolic or diastolic dysfunction predominates, and determines whether the cause of CHF is due to a myocardial, valvular, or pericardial process.</li>
<li>Estimates EF (very important): Patients with systolic dysfunction (EF &lt;40%) should be distinguished from patients with preserved left ventricular function (EF &gt;40%).</li>
<li>Shows chamber dilation and/or hypertrophy.</li>
</ul>
</li>
<li>B-type natriuretic peptide (BNP) is released from the ventricles in response to ventricular volume expansion and pressure overload.<ul>
<li>BNP levels &gt;100 pg/mL correlate strongly with the presence of decompensated CHF. (Unit of measurement varies.)</li>
<li>BNP may be useful in differentiating between dyspnea caused by CHF and COPD.</li>
<li>N-terminal pro-BNP (NT-proBNP) is a newer assay with similar predictive value as BNP. The normal range for this value depends on the age of the patient, but an NT-proBNP &lt;300 virtually excludes the diagnosis of HF.</li>
<li>BNP may be falsely low in obese patients.</li>
</ul>
</li>
<li>ECG is usually nonspecific but can be useful for detecting chamber enlargement and presence of ischemic heart disease or prior MI.</li>
<li>Radionuclide ventriculography using technetium-99m (“nuclear ventriculography”). Also called multigated acquisition (MUGA) scan.</li>
<li>Cardiac catheterization can provide valuable quantitative information regarding diastolic and systolic dysfunction, and can clarify the cause of CHF if noninvasive test results are equivocal. Consider coronary angiography to exclude CAD as an underlying cause of CHF.</li>
<li>Stress testing<ul>
<li>Identifies ischemia and/or infarction</li>
<li>Quantifies level of conditioning</li>
<li>Can differentiate cardiac versus pulmonary etiology of dyspnea</li>
<li>Assesses dynamic responses of HR, heart rhythm, and BP</li>
</ul>
</li>
</ul>
<hr/>
<h1 id="heart-failure-with-reduced-ejection-fraction-hfref">Heart failure with reduced ejection fraction (HFrEF)</h1>
<h2 id="management">Management</h2>
<ul>
<li>
<p><strong>Pharmacotherapy for HFrEF as recommended by eTG:</strong></p>
<ul>
<li>ACEi &amp; Beta-blockers &amp; Spironolactone FIRST - <strong>MORTALITY LOWERING DRUGS</strong><ul>
<li>Serum sodium, potassium, renal function and blood pressure should be measured prior to starting a mineralocorticoid receptor antagonist and with every dose increase.</li>
<li>If you cannot use an ACEi/ARB, use beta blocker + arteriodilator (hydralazine) + venodilator (isosorbide nitrate)</li>
</ul>
</li>
<li>Add frusemide/loop diuretics if patient is fluid retentive<ul>
<li>Creatinine rise, hyperkalemia or hypotension possible when starting medications → continue, unless symptomatic</li>
</ul>
</li>
<li>if ACEi is maxed out and pt is symptomatic → replace with ARNI (sacubitril/valsartan)<ul>
<li>Ivabradine: sinus rhythm &gt; 75bpm, LVF &lt; 35%</li>
<li>Sacubitril/Valsartain - LVEF &lt; 35%, initiated after ACEi/ARB washout (36h)</li>
<li>Digoxin: Inotropic, symptomatic only (strong indication if co-existing AF)</li>
</ul>
</li>
<li>
<p>IV Fe if anemic</p>
</li>
<li>
<p>General lifestyle modification</p>
<ul>
<li>Sodium restriction (less than 4 g/day)</li>
<li>Fluid restriction (1.5 to 2.0 L daily)</li>
<li>Weight loss</li>
<li>Smoking cessation</li>
<li>Restrict alcohol use</li>
<li>Exercise program</li>
<li>All patients should monitor weight daily to detect fluid accumulation</li>
<li>Annual influenza vaccine and pneumococcal vaccine recommended</li>
</ul>
</li>
<li><strong>Diuretics</strong><ul>
<li>Most effective means of providing symptomatic relief to patients with moderate to severe CHF</li>
<li>Recommended for patients with systolic failure and volume overload</li>
<li>Have not been shown to reduce mortality or improve prognosis, just for symptom control.<ul>
<li>Goal is relief of signs and symptoms of volume overload (dyspnea, peripheral edema)</li>
</ul>
</li>
<li>Loop diuretics: Furosemide (Lasix)—usually used. Other options include bumetanide (Bumex) and torsemide</li>
<li>Thiazide-like diuretics: Metolazone and chlorothiazide. Used to augment diuresis with loop diuretics</li>
</ul>
</li>
<li>Therapies to improve outcomes: Standard therapy includes the following (medications in parentheses have been shown to improve mortality in HFrEF):<ul>
<li><strong>ACE inhibitor (enalapril, lisinopril, captopril) or ARB (valsartan, losartan, candesartan)</strong></li>
<li>nitroprusside is an <strong>afterload reducer</strong></li>
<li><strong>β-Blockers (metoprolol succinate, carvedilol, bisoprolol, nebivolol)</strong></li>
<li><strong>Aldosterone antagonists (spironolactone, eplerenone), if EF &lt;35%</strong></li>
</ul>
</li>
<li>Primary prevention of sudden cardiac death with ICD implantation if EF &lt;35% on optimal medical therapy <ul>
<li>Hydralazine and nitrates (isosorbide dinitrate) are an effective combination therapy for African American patients with HFrEF. These are also often used for patients who cannot take ACEi/ARB or aldosterone antagonists due to renal dysfunction</li>
<li>Sacubitril/valsartan is an angiotensin receptor/neprilysin inhibitor (ARNI) that can be used in patients with EF &lt;35% with maximally tolerated ACEi or ARB, and has been shown to improve mortality (PARADIGM-HF trial)</li>
<li>Ivabradine is a funny channel inhibitor that has been shown to reduce hospitalizations in patients with reduced EF and HR &gt;70 on maximally tolerated β-blocker therapy</li>
<li>Digoxin was once regularly used for HFrEF, but has not been shown to improve mortality</li>
<li><strong><em>Diuretics (lasix/frusemide) and digoxin do NOT lower mortality</em></strong></li>
</ul>
</li>
</ul>
</li>
</ul>
<p>Primary prevention ICD implantation is recommended for patients who are receiving optimal medical therapy, have a reasonable expectation of survival with good functional status for more than 1 year, and have:
    - left ventricular ejection fraction 35% or less, with mild to moderate heart failure symptoms (New York Heart Association [NYHA] Class 2 and 3), or
    - left ventricular ejection fraction 30% or less, at least one month after a myocardial infarction.</p>
<hr/>
<h1 id="heart-failure-with-preserved-ejection-fraction-hfpef">Heart failure with preserved ejection fraction (HFpEF)</h1>
<h2 id="management_1">Management</h2>
<ul>
<li>
<p><strong>Pharmacotherapy of HFpEF as recommended by eTG:</strong></p>
<ul>
<li>ACEi &amp; Beta-blockers recommended FIRST, but in general you use the same medication as you do with HFrEF</li>
<li>Following need to be considered and avoided:<ul>
<li>diuretics—patients with HFpEF generally have normal left ventricular volume and are sensitive to diuretics. Excessive diuresis can lead to a severe reduction in cardiac output and blood pressure</li>
<li>venodilators (eg isosorbide dinitrate), which can cause a severe reduction in cardiac output and blood pressure</li>
<li>powerful arterial vasodilators (eg hydralazine), which can cause dynamic left ventricular outflow obstruction</li>
<li>digoxin and other inotropic drugs, which should be avoided unless the patient is in atrial fibrillation - no need for positive inotropes as in HFpEF output is adequate</li>
</ul>
</li>
</ul>
</li>
<li>
<p>HFpEF: Few therapeutic options available; patients are treated symptomatically (NO medications have proven mortality benefit)</p>
<ul>
<li>Diuretics are used for symptom control (volume overload)</li>
<li>Patients should continue salt and fluid restriction, take daily weights</li>
<li>No other drug classes have been shown to produce significant mortality benefit in randomized controlled trials</li>
</ul>
</li>
</ul></div>
</div>
</div>
<footer class="col-md-12">
<hr/>
<p>Copyright © 2021 Weber Liu</p>
</footer>
<script>
            var base_url = "../..",
                shortcuts = {"help": 191, "next": 78, "previous": 80, "search": 83};
        </script>
<script defer="" src="../../js/base.js"></script>
<script defer="" src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
<script defer="" src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script>
<script defer="" src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
<script defer="" src="../../search/main.js"></script>
<div aria-hidden="true" aria-labelledby="searchModalLabel" class="modal" id="mkdocs_search_modal" role="dialog" tabindex="-1">
<div class="modal-dialog modal-lg">
<div class="modal-content">
<div class="modal-header">
<h4 class="modal-title" id="searchModalLabel">Search</h4>
<button class="close" data-dismiss="modal" type="button"><span aria-hidden="true">×</span><span class="sr-only">Close</span></button>
</div>
<div class="modal-body">
<p>From here you can search these documents. Enter your search terms below.</p>
<form>
<div class="form-group">
<input class="form-control" id="mkdocs-search-query" placeholder="Search..." title="Type search term here" type="search"/>
</div>
</form>
<div data-no-results-text="No results found" id="mkdocs-search-results"></div>
</div>
<div class="modal-footer">
</div>
</div>
</div>
</div><div aria-hidden="true" aria-labelledby="keyboardModalLabel" class="modal" id="mkdocs_keyboard_modal" role="dialog" tabindex="-1">
<div class="modal-dialog">
<div class="modal-content">
<div class="modal-header">
<h4 class="modal-title" id="keyboardModalLabel">Keyboard Shortcuts</h4>
<button class="close" data-dismiss="modal" type="button"><span aria-hidden="true">×</span><span class="sr-only">Close</span></button>
</div>
<div class="modal-body">
<table class="table">
<thead>
<tr>
<th style="width: 20%;">Keys</th>
<th>Action</th>
</tr>
</thead>
<tbody>
<tr>
<td class="help shortcut"><kbd>?</kbd></td>
<td>Open this help</td>
</tr>
<tr>
<td class="next shortcut"><kbd>n</kbd></td>
<td>Next page</td>
</tr>
<tr>
<td class="prev shortcut"><kbd>p</kbd></td>
<td>Previous page</td>
</tr>
<tr>
<td class="search shortcut"><kbd>s</kbd></td>
<td>Search</td>
</tr>
</tbody>
</table>
</div>
<div class="modal-footer">
</div>
</div>
</div>
</div>
</body>
</html>
